Tuesday, March 17, 2026

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

BMW Drops Five Limited Models—Only 65 Units Available Online

BMW Korea unveils five limited-edition models, including the i7 xDrive60 and 750e xDrive, showcasing unique designs and performance.

Tag: Chung Kyong-taek

No posts to display

Top News

- Our Sponsors Ad -

Follow us